Benzyl 5-bromo-2,3-dihydro-1H-isoindole-2-carboxylate

Catalog No. :
ACRCDO279
CAS No. :
178445-27-7
Molecular Formula :
C16H14BrNO2
Molecular Weight :
332.20

IUPAC Name:benzyl 5-bromoisoindoline-2-carboxylate

Benzyl 5-bromo-2,3-dihydro-1H-isoindole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$99.00Login to see priceIn stockIn stock
250mg95%$168.00Login to see priceIn stockIn stock
1g95%$457.00Login to see priceIn stockIn stock
5g95%$2260.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 5-bromo-2,3-dihydro-1H-isoindole-2-carboxylate
IUPAC Namebenzyl 5-bromoisoindoline-2-carboxylate
MDL No.MFCD14635572
Molecular FormulaC16H14BrNO2
Molecular Weight332.20
SMILESO=C(N1CC2=C(C=C(Br)C=C2)C1)OCC3=CC=CC=C3
InChI KeyLZCLZPXCOKSFNU-UHFFFAOYSA-N
Synonym5-Bromo-1,3-dihydro-isoindole-2-carboxylic acid benzyl ester;2H-Isoindole-2-carboxylic acid, 5-bromo-1,3-dihydro-, phenylmethyl ester;benzyl 5-bromoisoindoline-2-carboxylate;benzyl 5-bromo-2,3-dihydro-1H-isoindole-2-carboxylate
CAS No.178445-27-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACRCDO279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJFRX751 route compound structure diagram
    ACJFRX751919346-89-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRCDO279 route product structure diagram
    ACRCDO279178445-27-7 In Stock
Inquiry

2. ACRCDO279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRCDO279 route product structure diagram
    ACRCDO279178445-27-7 In Stock
Inquiry

Comments (0)